Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (NDUFS4), is a nuclear-encoded accessory subunit of mitochondrial respiratory chain complex I (NADH:ubiquinone oxidoreductase). It is a peripheral membrane protein located on the matrix side of the inner mitochondrial membrane and contributes to electron transport from NADH to ubiquinone, facilitating ATP synthesis via oxidative phosphorylation. Although NDUFS4 is not directly involved in catalysis, it is essential for proper assembly and stabilization of complex I and may be regulated by phosphorylation. Mutations cause mitochondrial complex I deficiency, Leigh syndrome, and are associated with a broad spectrum of multi-organ mitochondrial diseases, especially neurological and muscular phenotypes; these disorders are often severe and clinically heterogeneous.
Direct inhibition of complex I (e.g., by rotenone, reducing electron transport and ATP production)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (NDUFS4).